Natixis’s Encompass Health EHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$8.11M Sell
83,827
-39,500
-32% -$4.05M 0.03% 337
2025
Q4
$13.1M Buy
+123,327
New +$14.3M 0.05% 289
2025
Q3
Sell
-3,294
Closed -$404K 1109
2025
Q2
$404K Sell
3,294
-681
-17% -$77.8K ﹤0.01% 729
2025
Q1
$400K Sell
3,975
-803
-17% -$78.4K ﹤0.01% 684
2024
Q4
$441K Buy
+4,778
New +$469K ﹤0.01% 729
2024
Q3
Sell
-239
Closed -$20.5K 1002
2024
Q2
$20.5K Sell
239
-616
-72% -$51.7K ﹤0.01% 818
2024
Q1
$70.6K Buy
855
+530
+163% +$38.8K ﹤0.01% 804
2023
Q4
$21.7K Buy
+325
New +$21.1K ﹤0.01% 876
2023
Q2
Sell
-669
Closed -$36.2K 1055
2023
Q1
$36.2K Buy
+669
New +$38.9K ﹤0.01% 848
2019
Q3
Sell
-81,264
Closed -$4.1M 835
2019
Q2
$4.1M Sell
81,264
-236,899
-74% -$11.5M 0.03% 361
2019
Q1
$14.8M Buy
318,163
+276,416
+662% +$14M 0.09% 210
2018
Q4
$2.05M Buy
41,747
+36,718
+730% +$2.09M 0.02% 419
2018
Q3
$312K Sell
5,029
-6,280
-56% -$382K ﹤0.01% 680
2018
Q2
$609K Sell
11,309
-3,723
-25% -$186K ﹤0.01% 669
2018
Q1
$684K Buy
+15,032
New +$644K ﹤0.01% 636
2017
Q4
Sell
-28,293
Closed -$1.04M 925
2017
Q3
$1.04M Buy
28,293
+16,163
+133% +$576K 0.01% 512
2017
Q2
$467K Sell
12,130
-3,031
-20% -$111K 0.01% 538
2017
Q1
$516K Buy
15,161
+5,661
+60% +$186K 0.01% 505
2016
Q4
$312K Buy
+9,500
New +$308K ﹤0.01% 621

Other funds holding EHC

Natixis's EHC Position: Q1 2026 in Review

Natixis reduced its Encompass Health (EHC) stake by 32% in Q1 2026, selling an estimated $4.05M and leaving 83,827 shares worth $8.11M. The position accounts for 0.03% of the portfolio, ranked #337.

Natixis first reported a position in EHC in Q4 2016 and has held it in 19 quarters since. The position peaked at $14.8M in Q1 2019. 577 funds tracked by Wall St. Rank hold EHC as of Q1 2026.

  • Natixis held 83,827 shares of Encompass Health worth $8.11M as of Q1 2026.
  • Natixis sold 39,500 Encompass Health shares in Q1 2026, an estimated $4.05M.
  • Encompass Health made up 0.03% of Natixis's portfolio in Q1 2026, its #337 holding.
  • Natixis first reported a position in Encompass Health in Q4 2016 and has held it in 19 quarters since.
  • Natixis's Encompass Health position peaked at $14.8M in Q1 2019.
  • 577 funds tracked by Wall St. Rank held Encompass Health as of Q1 2026.

Based on Natixis's 13F filing for Q1 2026, filed 14 May 2026.